the effect of silymarin ( legalon ) upon liver lesions was investigated using four experimental models : in acute galactosamine-hepatitis , silymarin administration achieved protection of the liver structure ( electron-microscopy included ) , liver cell glycogen , rna and enzymatic activity , galactosamine-depressed gluconeogenesis in the isolated perfused rat liver was significantly preserved by silymarin treatment .
C0267797
acute
C0023884
of